Hi InvestotPaul
- looks like they are going to amalgamate with other resources in the area to boost total resource.
- I assumed 70% MHM, 30% other
- yes the Capex being floated around is at $500M
- from here I want the other way and asked what return or payback would the new company want on its capex. Probably a high of ten years to a low of five years. For arguments sake lets say seven.
- we then end up with an EBITDA of $500m/7 = $70M
- say half debt funded - therefore interest cost = $20M
- Net profit before tax = $50M
- Depreciation on $500M would be $25-40M so negligible tax (say) $10M
- Therefore NPBT = $40M. PE ratio of 12 = $480M market cap.
- Agree that the company holding the resource would be 20-25% and then take 70% of that = 15%. I have major at 40% and IPO at 45%. To attract investors and taking into account 2-3 year build forward PE say at 8 therefore new company floated at $320M - IPO raises 45% = $144M + $128M from major shareholder (40%) = $272M which is roughly half the value of the required capex which agrees to my earlier assumption.
So a mc of $320M of which MHM shareholders receive 15% = $48M = about 35c/share.
Now probably more by good luck than good measure but basically get about the same as you Investorpaul but by using another method,
Spozzie
- Forums
- ASX - By Stock
- VYS
- potential value of the silica project to mhm
VYS
vysarn limited
Add to My Watchlist
5.32%
!
49.5¢

potential value of the silica project to mhm, page-4
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
49.5¢ |
Change
0.025(5.32%) |
Mkt cap ! $261.0M |
Open | High | Low | Value | Volume |
47.5¢ | 50.0¢ | 46.3¢ | $783.5K | 1.639M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 150 | 48.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
50.0¢ | 159525 | 7 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 150 | 0.485 |
2 | 30000 | 0.480 |
2 | 8200 | 0.475 |
2 | 31000 | 0.470 |
3 | 37100 | 0.460 |
Price($) | Vol. | No. |
---|---|---|
0.500 | 159525 | 7 |
0.505 | 40000 | 2 |
0.510 | 21505 | 1 |
0.520 | 29636 | 3 |
0.525 | 50000 | 1 |
Last trade - 16.13pm 01/07/2025 (20 minute delay) ? |
Featured News
VYS (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Dr. Steven Gourlay, CEO
Dr. Steven Gourlay
CEO
Previous Video
Next Video
SPONSORED BY The Market Online